Monocyte-to-HDL Ratio
An experimental ratio pairing pro-inflammatory monocytes against anti-inflammatory HDL particles.
Primary Biological Role: Contrasts pro-atherogenic inflammatory cell counts with protective, reverse-cholesterol-transport HDL particles.
Evidence Score
Evidence Dimension Breakdown
Overview
The Monocyte-to-HDL Cholesterol Ratio (MHR) is a hybrid metric calculated by dividing the absolute monocyte count (cells/µL) by high-density lipoprotein cholesterol (HDL-C in mg/dL). It is positioned by advanced health platforms as a simultaneous assessment of pro-inflammatory vascular drive and anti-inflammatory lipid defense.
Biological Mechanism
Monocytes differentiate into tissue macrophages and ingest oxidized LDL to become foam cells within the arterial intima. HDL particles exert counter-regulatory anti-inflammatory effects by inhibiting monocyte activation, promoting endothelial repair, and facilitating reverse cholesterol transport. A high MHR reflects elevated monocyte recruitment paired with depleted HDL protection.
Clinical Trial & Outcome Evidence
Demonstrated to correlate with coronary artery disease severity, slow coronary flow, and carotid intima-media thickness in observational cardiology literature.
Analytical Limitations & Confounders
Because HDL-C sits in the denominator and moves for reasons unrelated to immune activation — diet, alcohol, weight change, thyroid status, lipid-lowering therapy — any change in MHR must be decomposed into its monocyte and HDL components before it is read as a change in inflammation. HDL cholesterol concentration reflects cholesterol mass rather than HDL particle count (HDL-P) or functional efflux capacity. Monocyte differentials can vary based on automated hematology analyzer methodology. Sex-specific reference percentiles have been proposed (Arabi 2025, PMID 41131556), but no consensus clinical cutoff exists.
Kinetics & Retesting Frequency
Monocyte counts and HDL levels shift over weeks in response to dietary modifications, exercise regimens, and lipid-lowering therapies.
Frequently Asked Questions
What does the Monocyte-to-HDL Ratio measure?
MHR measures the balance between pro-inflammatory circulating monocytes (which infiltrate blood vessel walls) and protective HDL cholesterol particles.
Is MHR superior to standard lipid panels?
Not independently. MHR is a supplementary research ratio. Standard lipid markers (such as ApoB and LDL particle counts) carry far stronger prospective outcome validation.
Biomarker Profile
- Class
- Immune Cell Ratio
- Score
- 46/100
- Grade
- C
Key Published Studies
Related Biomarkers
Related Panel Patterns
Track Your Inflammation — Cohort Now Forming
Track your own inflammatory gene expression over time. Reserve your spot in the Inflammation Compass founding cohort today to lock in early pricing before the general public.